POSTER: CT-312 The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil

Articles > Article · 2023

Authors: Julia Carvalho, Mauricio Cupello, Romulo Medina

Clinical Lymphoma Myeloma and Leukemia, International, WoS, 2023, vol 23, pp S230-S230

DOI: 10.1016/s2152-2650(23)00891-1

View details